MiMedx will highlight its HydroFix Vaso Shield and AmnioFix Amniotic Membrane Allografts. The HydroFix Vaso Shield is an FDA-approved device designed for vessel protection during anterior vertebral surgery. MiMedx’s AmnioFix is processed from the human amniotic membrane through proprietary technology to produce an implant that is safe, effective and minimally manipulated.
Read the news release about MiMedx’s orthopedic and spine products.
Read other coverage about MiMedx:
– MiMedx Group Acquires Surgical Biologics
– MiMedx Receives FDA Clearance for HydroFix Vaso Shield
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
